Home > News & Conferences > Fast Facts

Financials

• In 2009, AIT's revenues increased 75%; In 2008, AIT's revenues increased 106% and net profits increased more than 400%
• In 2007, AIT’s revenues increased 80% and its net profits increased 170%
• AIT has more than 475 employees nationwide. In 2005, AIT had 71 employees
• AIT has added more than 100 jobs in 2010; Added nearly 180 jobs in 2009 and 90 jobs in 2008. AIT also added 60 new jobs in 2007
• AIT employs more than 75 full-time chemists and Ph.D.-level toxicologists
• AIT nearly doubled its national sales force and entered 15 new markets in 2009
• In 2009, AIT returned 25 percent of its net profit back to employees in a net profit sharing bonus
• AIT gave employees more than $3 million in bonuses in 2008 and 2009 and $1 million in 2007
• In 2009, AIT formed a new division, AIT Bioscience, a bioanalytical contract research organization
  

Employees

• On July 1, 2009, AIT Founder, President, and CEO Michael A. Evans, Ph.D. transferred ownership of AIT to his employees in an Employee Stock Ownership Plan (ESOP)
• AIT offers employees $5,000 in tuition reimbursement annually
• More than 16 percent of AIT employees are enrolled in continuing education
• More than 10 percent of AIT employees have masters or Ph.D. degrees
• More than 55 percent of AIT employees have received or are receiving degrees at an Indiana college or university
• More than 17 percent of AIT employees have joined the company due to referrals from other employees
  

Technology

• AIT uses a variety of instruments, including the Aeroset, GC/MS, LC/MS, UPLC-MS/MS, UPLC coupled with Time-of-Flight mass spectrometry. 
• AIT first started using LC/MS technology in 2001 and has more than 100 years of combined intellectual experience using LC/MS
• AIT prides itself on being a science-based, technology-driven company
• AIT can identify all drug substances in just one test using UPLC coupled with Time-of-Flight mass spectrometry 
• AIT owns one of the largest spectral library database of compounds in North America using Time-of-Flight technology

Culture

• AIT operates under an atmosphere of integrity, respect, and gratitude for its employees and clients
• AIT has been named one of the "Best Places to Work in Indiana" for three consecutive years
• AIT is committed to giving back to the communities in which it serves.  In 2009, AIT's Contributions Committee donated nearly $100,000 to 45 different charitable organizations
• AIT gives its employees time off from work to volunteer for various organizations
• AIT offers quarterly bonuses to employees when the company is profitable
• AIT provides a matching 401(k) with 100% vestment of funds upon deposit
• AIT has formed a Quality of Life Committee to better the lives of its employees. 
• In 2009, AIT created more than 100 new cultural initiatives to benefit employees
• AIT has a wellness manager that oversees wellness initiatives for AIT employees including a wellness month, twice yearly health screenings, free flu shots, personal wellness plans and more. In 2010, AIT was named a "Fit-Friendly Company" by the American Heart Association.

Top News Stories

AIT Publishes Article About Compliance Monitoring and Risk Mitigation in “Practical Pain Management”

In the June 2010 issue of Practical Pain Management, AIT CEO Michael A. Evans, Ph.D. and several of the company’s toxicologists published an expert article about compliance monitoring as it relates to risk mitigation. The article outlines how laboratory screening and confirmation combined with physician education can support an effective risk mitigation strategy.

AIT Laboratories Announces New Headquarters

On June 17, Indiana Governor Mitch Daniels, Indianapolis Mayor Greg Ballard, and AIT Laboratories CEO Michael Evans, Ph.D. announced the company’s plans to open a new corporate headquarters facility in the Woodland Corporate Park on the northwest side of Indianapolis. With the new headquarters, AIT will create up to 160 new jobs by 2014.

AIT CEO Joins Board of Directors for newly formed Perfinity BioSciences

AIT is proud to announce that CEO Michael A. Evans, Ph.D. was invited to join the board of directors for Perfinity BioSciences, Inc., a newly formed entity that recently raised $2.33 million in new capital. Perfinity was formed by Quadraspec, Inc. to pursue a new business plan, focusing on sample preparation techniques and tools to facilitate mass spectrometry.